In addition, while the expression of the cell cycle progression inhibitor CDKN1A (p21) was decreased in cancer EVs-exposed cells, the expression of the oncogenes MYC and HRAS was increased (Fig. 6a). The gene discussed is HRAS; the disease is cancer.